Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 2009Annals of NeurologyOpen Access

Current hypotheses for the underlying biology of amyotrophic lateral sclerosis

View Full Paper
Ask AI
Bookmark
Share

Authors

Jeffrey D. RothsteinJeffrey D. RothsteinKanazawa University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Jeffrey D. Rothstein (2009) studied this question.

synapsesocial.com/papers/69dff88e2833447a7e255bechttps://doi.org/10.1002/ana.21543
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1A placebo-controlled trial of insulin-like growth factor-I in amyotrophic lateral sclerosis1998 · 342 citations
  2. 2Depletion of TDP 43 overrides the need for exonic and intronic splicing enhancers in the human apoA-II gene2005 · 226 citations
  3. 3Restricted Expression of G86R Cu/Zn Superoxide Dismutase in Astrocytes Results in Astrocytosis But Does Not Cause Motoneuron Degeneration2000 · 368 citations
  4. 4Retrograde Viral Delivery of IGF-1 Prolongs Survival in a Mouse ALS Model2003 · 874 citations
  5. 5Caspase-1 and -3 are sequentially activated in motor neuron death in Cu,Zn superoxide dismutase-mediated familial amyotrophic lateral sclerosis2000 · 350 citations